| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6177552 | European Urology | 2016 | 10 Pages |
Abstract
These findings implicate low-molecular-weight protein tyrosine phosphatase as a novel oncogene in prostate cancer and could offer the possibility of using this protein as biomarker or target for treatment of this disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Roberta R. Ruela-de-Sousa, Elmer Hoekstra, A. Marije Hoogland, Karla C. Souza Queiroz, Maikel P. Peppelenbosch, Andrew P. Stubbs, Karin Pelizzaro-Rocha, Geert J.L.H. van Leenders, Guido Jenster, Hiroshi Aoyama, Carmen V. Ferreira, Gwenny M. Fuhler,